Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Precedex and Katalar for Shivering Control
NCT03302351Phase 4Completed
- Sponsor
- Assiut University
- Start
- Oct 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine and ketamine, sponsored by Assiut University. Primary endpoint: Shivering at 10 minutes. Started Oct 2017; status: completed.
02
Drugs
dexmedetomidineketamine
Beyond the preview
Go deeper on NCT03302351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03302351.